These studies demonstrated that PAX1 gene is silenced by promoter methylation in cervical cancer and proposed it as a molecular biomarker for cervical cancer screening and diagnosis; however, it has been barely studied for radiation response in cervical cancer. Here, PAX1 is linked to cervical carcinoma.